Role of indoleamine 2, 3-dioxygenase in health and disease

AWS Yeung, AC Terentis, NJC King… - Clinical …, 2015 - portlandpress.com
IDO1 (indoleamine 2, 3-dioxygenase 1) is a member of a unique class of mammalian haem
dioxygenases that catalyse the oxidative catabolism of the least-abundant essential amino …

RNA interference-induced innate immunity, off-target effect, or immune adjuvant?

Z Meng, M Lu - Frontiers in immunology, 2017 - frontiersin.org
RNA interference (RNAi) is a natural cellular mechanism that inhibits gene expression in a
sequence-specific manner. In the last decade, RNAi has become a cornerstone in basic …

Immunomodulatory effects mediated by serotonin

R Arreola, E Becerril-Villanueva… - Journal of …, 2015 - Wiley Online Library
Serotonin (5‐HT) induces concentration‐dependent metabolic effects in diverse cell types,
including neurons, entherochromaffin cells, adipocytes, pancreatic beta‐cells, fibroblasts …

Control of immune response by amino acid metabolism

U Grohmann, V Bronte - Immunological reviews, 2010 - Wiley Online Library
The interaction between pathogenic microorganisms and their hosts is regulated by
reciprocal survival strategies, including competition for essential nutrients. Though …

Noncanonical NF-κB activation mediates STAT3-stimulated IDO upregulation in myeloid-derived suppressor cells in breast cancer

J Yu, Y Wang, F Yan, P Zhang, H Li, H Zhao… - The Journal of …, 2014 - journals.aai.org
Immunotherapy for cancer treatment is achieved through the activation of competent
immune effector cells and the inhibition of immunosuppressive cells, such as myeloid …

NK cell-based therapeutics for lung cancer

AG Pockley, P Vaupel, G Multhoff - Expert opinion on biological …, 2020 - Taylor & Francis
Introduction: Lung cancer is a devastating disease with poor overall survival. Despite
significant advances in the treatment of lung cancers using radiochemotherapy, targeted …

Suppression of immunostimulatory siRNA-driven innate immune activation by 2′-modified RNAs

M Sioud, G Furset, L Cekaite - Biochemical and biophysical research …, 2007 - Elsevier
Single-stranded (ss) and double-stranded (ds) small interfering RNAs (siRNAs) containing
immunostimulatory RNA motifs can activate innate immunity through Toll-like receptor 7/8 …

Indoleamine 2, 3-dioxygenase specific, cytotoxic T cells as immune regulators

RB Sørensen, SR Hadrup, IM Svane… - Blood, The Journal …, 2011 - ashpublications.org
Abstract Indoleamine 2, 3-dioxygenase (IDO) is an immunoregulatory enzyme that is
implicated in suppressing T-cell immunity in normal and pathologic settings. Here, we …

The absence of IDO upregulates type I IFN production, resulting in suppression of viral replication in the retrovirus-infected mouse

M Hoshi, K Saito, A Hara, A Taguchi… - The Journal of …, 2010 - journals.aai.org
Abstract Indoleamine 2, 3-dioxygenase, the l-tryptophan–degrading enzyme, plays a key
role in the powerful immunomodulatory effects on several different types of cells. Because …

CARD9 prevents lung cancer development by suppressing the expansion of myeloid‐derived suppressor cells and IDO production

J Qu, L Liu, Q Xu, J Ren, Z Xu, H Dou… - … journal of cancer, 2019 - Wiley Online Library
Caspase recruitment domain‐containing protein 9 (CARD9) is an adaptor protein and highly
expressed in myeloid cells. Our previous study demonstrates a critical protective effect of …